One Stop Prostate Biopsy Protocol Author Consultation Date Approved

Size: px
Start display at page:

Download "One Stop Prostate Biopsy Protocol Author Consultation Date Approved"

Transcription

1 One Stop Prostate Biopsy Protocol Author Consultation Date Approved Urology Nurse Practioner

2 PROTOCOL FOR MEN ATTENDING A ONE STOP PROSTATE BIOPSY CLINIC RATIONALE Prostate cancer is the most common cancer in men in the united kingdom and accounts for 24% of all new male cancers. This equates to approximately 37,000 new cases being diagnosed annually. There are currently three commonly used procedures to diagnose prostate cancer; digital rectal examination (DRE), the PSA blood test and trans rectal ultrasound scan (TRUS) and needle biopsy. DRE & PSA combined, increases the predictive value of prostate cancer, and are therefore considered essential before proceeding with biopsies. PURPOSE The aim of the protocol is to provide the urology nurse with clear guidelines for the assessment and investigation of patients suspected of having prostate cancer. In addition to this it aids with: Streamlining the patient pathway Reduce waiting times Compliance of government targets Cost effectiveness SCOPE The protocol is aimed at patients that have had an initial assessment with a healthcare professional and have been deemed as suspected of having prostate cancer by them, as set out in NICE referral guidelines for suspected cancer ( 2005). PROTOCOL DETAILS The urology nurse responsible for co coordinating the management of these patients will be an experienced urological nurse practitioner. The nurse must

3 be competent to assess and make decisions independently when required, or after consultation with the urological consultant. The nurse practitioner will have in depth knowledge and be deemed competent by a designated mentor in: Signs & Symptoms of prostate cancer History taking Interpretation of the physical examination, history taking and initial investigations that have been carried out Risk factors Consent Prostate biopsy procedure Further investigations Treatments available: o Watchful Waiting o Active Surveillance o Radical Prostatectomy o Radiotherapy o Brachytherapy o Hormonal therapy Interpretation of histopathological prostate biopsy reports REFERRALS Patients can be referred via GP s, Practice Nurses, and secondary care Consultants. All referrals are to be screened by a Consultant, Associate Specialist or Urology Nurse Practitioner EXCLUSION CRITERIA FOR A ONE STOP PROSTATE BIOPSY One elevated PSA No MSU Severe Morbidity > 75 years

4 Patient taking Anticoagulants Previous negative prostate biopsies All aspects of the Nurse led part of the one stop prostate biopsy clinic are protocol led and have been established in accordance with NICE Prostate Cancer: diagnosis and treatment (2008) and approved by all the Urology Consultants at Cwm Taf LHB. Any deviations that may arise outside of the protocol should be discussed with the individual Consultant that the patient is under the care of.

5 REFERENCES National Institute for Health and Clinical Excellence (2008) Prostate Cancer: diagnosis and treatment full guideline National Collaborating Centre for Cancer: Wales National Institute for Health and Clinical Excellence (2005) Referral Guidelines for Suspected Cancer National Collaborating Centre for Cancer

6 Patient Pathway Referral to Appointment 1. Referral received and date stamped by urology secretaries 2. Referral screened: a. More clinical information required i. Letter sent to referring GP and patient b. Listed for one stop prostate biopsy clinic i. Referral given to 1 st appointments with clinic date & time ii. X ray informed of date & time c. Listed for outpatient elevated PSA clinic i. Referral given to 1 st appointments with OP clinic date 3. Appointment sent out by 1 st appointments to the patient including information re: a. PSA testing b. The biopsy procedure c. Contact number of the nurse practitioner Administration for the patients identified as being suitable to attend the one stop prostate biopsy clinic 1. Notes requested from medical records as soon as referral reviewed 2. Notes reviewed to confirm suitability 3. Patient information entered onto the one stop prostate biopsy database 4. X ray informed if any patient identified is not suitable 5. Prescription for patient completed for prophylactic antibiotics and taken to pharmacy 6. Prescriptions delivered to urology nurse practitioner Prostate Biopsy Clinic 1. Patient attends the outpatient department and is reviewed by the nurse practitioner in clinic. Proforma completed. The review will include obtaining a / and providing: a. Reason for referral b. Clinical History

7 c. Clinical examination d. +/- flow rate and post void residual e. Adverse effects of biopsies f. Consent g. FU options discussed i. FU in clinic ii. Telephone FU with urology nurse practitioner h. Antibiotic cover given 2. Patient taken to the X ray department for the procedure 3. Patient is received by radiology staff: a. Observations checked b. Consent checked 4. Patient taken into prostate biopsy suite 5. Prostate biopsy performed 6. Notes written in by Consultant and any complications documented. 7. Patient taken to recovery area a. Observations checked b. Pain level assessed c. Urine voided, checked for haematuria and recorded 8. Patient discharged home with: a. Contact helpline numbers b. Post biopsy information sheet c. Discharge summary for GP d. Remaining prophylactic antibiotics 9. Samples taken to pathology department 10. Notes returned to Urology 11. Letter dictated by urology nurse practitioner for typing by urology secretary

8

The Urology One-Stop Clinic

The Urology One-Stop Clinic The Urology One-Stop Clinic Exceptional healthcare, personally delivered The aim of this leaflet is to answer any questions you may have about the Urology One-Stop Clinic. What is the Urology One-Stop

More information

Delivering stratified follow-up in primary care for Prostate Cancer Patients - The NCL Approach. Dr Elizabeth Babatunde Macmillan GP

Delivering stratified follow-up in primary care for Prostate Cancer Patients - The NCL Approach. Dr Elizabeth Babatunde Macmillan GP Delivering stratified follow-up in primary care for Prostate Cancer Patients - The NCL Approach Dr Elizabeth Babatunde Macmillan GP Background 2 Objectives Enhance patient experience and outcomes by providing

More information

Guidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer

Guidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer Guidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group

More information

Appendix 4 Urology Care Pathways

Appendix 4 Urology Care Pathways Appendix 4 Urology Care Pathways Cancer Care Pathways outline the steps and stages in the patient journey from referral through to diagnostics, staging, treatment, follow up, rehabilitation and if applicable

More information

NICE BULLETIN Diagnosis & treatment of prostate cancer

NICE BULLETIN Diagnosis & treatment of prostate cancer Diagnosis & treatment of prostate cancer NICE provided the content for this booklet which is independent of any company or product advertised Diagnosis and treatment of prostate cancer Introduction In

More information

Table 1 Standards and items to set up a PCU: general requirements and critical mass

Table 1 Standards and items to set up a PCU: general requirements and critical mass Table 1 Standards and items to set up a PCU: general requirements and critical mass General requirements and European Prostate Cancer Units are structures managing sufficient volumes of patients with on-site

More information

Date Modified: May 29, Clinical Quality Measures for PQRS

Date Modified: May 29, Clinical Quality Measures for PQRS Date Modified: May 29, 2014 Clinical Quality s for PQRS # Domain Type Denominator Numerator Denominator Exclusions/Exceptions Rationale QCDR-1 QCDR-2 Patient Safety 102 Efficiency and Cost Reduction QCDR-3

More information

Date Modified: March 31, Clinical Quality Measures for PQRS

Date Modified: March 31, Clinical Quality Measures for PQRS Date Modified: March 31, 2015 2015 Clinical Quality s for PQRS # Domain Title Description Type Denominator Numerator Denominator Exclusions/Exceptions 1 Patient Safety Prostate Biopsy Antibiotic Process

More information

Attending for your Prostate Scan

Attending for your Prostate Scan Attending for your Prostate Scan Patient Information The aim of this booklet is to give you enough information: To help you prepare for your hospital visit To give properly informed consent for the procedure

More information

Trans-rectal Ultrasound Scan and Biopsy (TRUSS)

Trans-rectal Ultrasound Scan and Biopsy (TRUSS) Trans-rectal Ultrasound Scan and Biopsy (TRUSS) What is the prostate gland? The prostate is a small gland the size of a walnut. It is found at the base of the bladder and surrounds the urethra (water pipe).

More information

Single Suspected Cancer Pathway Definitions pathway start date

Single Suspected Cancer Pathway Definitions pathway start date Single Suspected Cancer Pathway Definitions pathway start date Date: March 2018 Version: 1.2.1 Wales Cancer Owner: Network and Welsh Government Status Published 1 P a g e Purpose of Document This document

More information

BLADDER PROSTATE PENIS TESTICLES BE YO ND YO UR CA NC ER

BLADDER PROSTATE PENIS TESTICLES BE YO ND YO UR CA NC ER BLADDER PROSTATE PENIS TESTICLES THE PROSTATE IS A SMALL, WALNUT-SIZED GLAND THAT IS PART OF THE MALE REPRODUCTIVE SYSTEM. IT RESTS BELOW THE BLADDER, IN FRONT OF THE RECTUM AND SURROUNDS PART OF THE URETHRA.

More information

LCA Lung Clinical Forum. 21 st October 2014

LCA Lung Clinical Forum. 21 st October 2014 LCA Lung Clinical Forum 21 st October 2014 Welcome Dr Liz Sawicka Chair - LCA Lung Pathway Group Succession planning Dr Kate Haire Consultant in Public Health Medicine, LCA Commissioning Intentions for

More information

Horizon Scanning Technology Briefing. Prostate cancer gene 3 (Progensa PCA3) assay in the diagnosis of prostate cancer

Horizon Scanning Technology Briefing. Prostate cancer gene 3 (Progensa PCA3) assay in the diagnosis of prostate cancer Horizon Scanning Technology Briefing National Horizon Scanning Centre Prostate cancer gene 3 (Progensa PCA3) assay in the diagnosis of prostate cancer December 2006 This technology summary is based on

More information

ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT FREQUENTLY-ASKED QUESTIONS

ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT FREQUENTLY-ASKED QUESTIONS The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E-mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk ADVICE TO

More information

The Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon

The Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon Prostate case study Presented by Mr Alan Thompson Consultant Urological Surgeon 2 Part one Initial presentation A 62 year old male solicitor attends your GP surgery. He has rarely seen you over the last

More information

Transrectal Ultrasound (Trus) Guided Prostate Biopsies Urology Patient Information Leaflet. Under review

Transrectal Ultrasound (Trus) Guided Prostate Biopsies Urology Patient Information Leaflet. Under review Transrectal Ultrasound (Trus) Guided Prostate Biopsies Urology Patient Information Leaflet What is the purpose of my appointment? Your doctor has informed us that you have an elevated Prostate Specific

More information

ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT

ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT Frequently-Asked Questions What is the aim of this leaflet? Prostate cancer is a serious condition. The PSA test, which can give an early indication of prostate cancer, is available to you if you want

More information

The European Board of Urology

The European Board of Urology Page 1 of 15 The European Board of Urology Sub-specialty certification application: Prostate cancer, A - General information A1 - APPLICATION IDENTIFICATION 1a. Application code blank 1b. EBU internal

More information

National Optimal Lung Cancer Pathway

National Optimal Lung Cancer Pathway National Optimal Lung Cancer Pathway This document was produced by the Lung Clinical Expert Group 2017 Document Title: National Optimal Lung Cancer Pathway and Implementation Guide Date of issue: August

More information

Faster Cancer Treatment Indicators: Use cases

Faster Cancer Treatment Indicators: Use cases Faster Cancer Treatment Indicators: Use cases 2014 Date: October 2014 Version: Owner: Status: v01 Ministry of Health Cancer Services Final Citation: Ministry of Health. 2014. Faster Cancer Treatment Indicators:

More information

THE UROLOGY GROUP

THE UROLOGY GROUP THE UROLOGY GROUP www.urologygroupvirginia.com 1860 Town Center Drive Suite 150/160 Reston, VA 20190 703-480-0220 19415 Deerfield Avenue Suite 112 Leesburg, VA 20176 703-724-1195 224-D Cornwall Street,

More information

Locally advanced prostate cancer

Locally advanced prostate cancer Diagnosis Helpline 0800 074 8383 prostatecanceruk.org 1 Locally advanced prostate cancer In this fact sheet: What is locally advanced prostate cancer? What tests are used to diagnose locally advanced prostate

More information

NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios

NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios How to use the case scenarios The case scenarios can be used in a training

More information

Transperineal ultrasound-guided biopsy of the prostate gland

Transperineal ultrasound-guided biopsy of the prostate gland PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient biopsy of the prostate gland affix patient label What is a transperineal (TP) ultrasound-guided prostate

More information

PROSTATE CANCER STRATIFIED FOLLOW UP. Hilary Baker Lead CNS for Uro-oncology MSc, BSc, RGN.

PROSTATE CANCER STRATIFIED FOLLOW UP. Hilary Baker Lead CNS for Uro-oncology MSc, BSc, RGN. PROSTATE CANCER STRATIFIED FOLLOW UP Hilary Baker Lead CNS for Uro-oncology MSc, BSc, RGN. LEARNING OBJECTIVES To refresh your knowledge about prostate cancer. To discuss the purpose and patient benefits

More information

Northern Ireland Prostate Cancer Service

Northern Ireland Prostate Cancer Service Northern Ireland Prostate Cancer Service Chris Hagan Consultant Urologist Clinical Director Urology and Transplant Belfast Trust (on behalf of Mr Nambi Rajan, NICaN Clinical Lead for Urology) Incidence

More information

Prostate cancer A guide for newly diagnosed men

Prostate cancer A guide for newly diagnosed men Prostate cancer A guide for newly diagnosed men 2 Prostate cancer A guide for newly diagnosed men About this booklet This booklet is for men who have recently been diagnosed with prostate cancer. It is

More information

Transrectal Ultrasound with Prostatic Biopsy

Transrectal Ultrasound with Prostatic Biopsy NHS Foundation Trust Michael Heal Department of Urology Transrectal Ultrasound with Prostatic Biopsy Every Matters 1 Introduction You have been referred to the Michael Heal Department of Urology for investigation

More information

Managing clinical outcomes for urological cancers

Managing clinical outcomes for urological cancers Managing clinical outcomes for urological cancers Netty Kinsella Uro-oncology nurse consultant The Royal Marsden Presentation Overview Variation in access to treatment across the LCA Introduce the LCA

More information

6 UROLOGICAL CANCERS. 6.1 Key Points

6 UROLOGICAL CANCERS. 6.1 Key Points 6 UROLOGICAL CANCERS 6.1 Key Points Prostate Cancer Commonest cancer in males in Scotland Approximately 99% of cases occur in men aged > 50 years About 40% of cases present in men aged < 70 years when

More information

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline Very Low-/Low-Risk Disease

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline Very Low-/Low-Risk Disease Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline Very Low-/Low-Risk Disease Jeffrey A. Cadeddu, MD Professor, Department of Urology UT Southwestern Medical Center Vice-Chair, AUA/ASTRO/SUO

More information

How to Integrate Continence Services and Secondary Care to Develop Pathways of Care.

How to Integrate Continence Services and Secondary Care to Develop Pathways of Care. How to Integrate Continence Services and Secondary Care to Develop Pathways of Care. Jenny Stuart. RGN, Post Reg Dip Nursing, Bmidwif (Hons), NMP, PG Dip. Continence Service Lead Community and Integrated

More information

Transrectal ultrasound scan & prostate biopsies (TRUS)

Transrectal ultrasound scan & prostate biopsies (TRUS) Transrectal ultrasound scan & prostate biopsies (TRUS) Exceptional healthcare, personally delivered Why do I need this procedure? This procedure is performed primarily to check for prostate cancer. Your

More information

A06/S(HSS)b Ex-vivo partial nephrectomy service (Adult)

A06/S(HSS)b Ex-vivo partial nephrectomy service (Adult) A06/S(HSS)b 2013/14 NHS STANDARD CONTRACT FOR EX-VIVO PARTIAL NEPHRECTOMY SERVICE (ADULT) PARTICULARS, SCHEDULE 2 THE SERVICES, A - SERVICE SPECIFICATION Service Specification No. Service Commissioner

More information

SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)

SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician GMCN ROYAL WOLVERHAMPTON HOSPITALS The Royal Wolverhampton Hospitals Trust Lung MDT (11-2C-1) - 2011/12 Dr Angela Morgan

More information

Prostate cancer smart screening, precision diagnosis, personalised treatment'

Prostate cancer smart screening, precision diagnosis, personalised treatment' Prostate cancer smart screening, precision diagnosis, personalised treatment' Prof. Hashim Ahmed PhD, FRCS(Urol), BM, BCh (Oxon), BA(Hons) Consultant Urological Surgeon Bupa Cromwell Hospital Clinics:

More information

Community care of Prostate Cancer. Shaun Costello Southern Cancer Network

Community care of Prostate Cancer. Shaun Costello Southern Cancer Network Community care of Prostate Cancer Shaun Costello Southern Cancer Network Introduction Why is GP follow up of prostate cancer important 4Years In Waikato Faster Cancer Treatment Reporting against the 3

More information

Getting to Diagnosis. Debbie Victor Uro-Oncology CNS Royal Cornwall Hospitals Trust

Getting to Diagnosis. Debbie Victor Uro-Oncology CNS Royal Cornwall Hospitals Trust Getting to Diagnosis Debbie Victor Uro-Oncology CNS Royal Cornwall Hospitals Trust GP Visit Symptoms Reduced urinary flow Difficulty starting/stopping Urgency Frequency Nocturia Because a friend/relative

More information

Non-QPP Measures. # Measure Title Definition Type Domain. Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys

Non-QPP Measures. # Measure Title Definition Type Domain. Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys Non-QPP Measures # Measure Title Definition Type Domain 1 Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys Percentage of patients (boys) =< 18 years of age newly diagnosed with undescended

More information

Prostate Artery Embolisation (PAE)

Prostate Artery Embolisation (PAE) Service: Imaging Prostate Artery Embolisation (PAE) Exceptional healthcare, personally delivered Ask 3 Questions The team delivering your healthcare want to encourage you to become as involved as possible

More information

creatinine lab order placed abdomen, MRI abdomen, ultrasound abdomen ordered or performed

creatinine lab order placed abdomen, MRI abdomen, ultrasound abdomen ordered or performed Non-QPP Measures # Measure Title Definition Type Domain 1 Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys Percentage of patients (boys) =< 18 years of age newly diagnosed with undescended

More information

Prostate Biopsy. Prostate Biopsy. We canʼt go backwards: Screening has helped!

Prostate Biopsy. Prostate Biopsy. We canʼt go backwards: Screening has helped! We canʼt go backwards: Screening has helped! Robert E. Donohue M.D. Denver V.A. Medical Center University of Colorado Prostate Biopsy Is cure necessary; when it is possible? Is cure possible; when it is

More information

SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)

SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician ASWCN TAUNTON AND SOMERSET Taunton Lung MDT (11-2C-1) - 2011/12 Dr Sarah Foster Compliance Self Assessment LUNG MDT

More information

Horizon Scanning Technology Briefing. Magnetic resonance spectroscopy for prostate cancer. National Horizon Scanning Centre.

Horizon Scanning Technology Briefing. Magnetic resonance spectroscopy for prostate cancer. National Horizon Scanning Centre. Horizon Scanning Technology Briefing National Horizon Scanning Centre Magnetic resonance spectroscopy for prostate cancer August 2006 This technology briefing is based on information available at the time

More information

BLADDER CANCER PATHWAY (E&W) Version 1

BLADDER CANCER PATHWAY (E&W) Version 1 BLADDER CANCER PATHWAY (E&W) Version 1 Flexi cysto FU (via cystoscopy) ptag1/2 and OP instillations MMC ptag3/cis BCG BCG cancer One-stop Haematuria Clinic TURBT Histology presented Decision to refer to

More information

Prostate Cancer Case Study 1. Medical Student Case-Based Learning

Prostate Cancer Case Study 1. Medical Student Case-Based Learning Prostate Cancer Case Study 1 Medical Student Case-Based Learning The Case of Mr. Powers Prostatic Nodule The effervescent Mr. Powers is found by his primary care provider to have a prostatic nodule. You

More information

TOOKAD (padeliporfin) Patient Information Guide

TOOKAD (padeliporfin) Patient Information Guide TOOKAD (padeliporfin) Patient Information Guide TOOKAD is used to treat low-risk localized prostate cancer This medicine is subject to additional monitoring. This will allow quick identification of new

More information

2012/13 NHS STANDARD CONTRACT FOR ACUTE, AMBULANCE, COMMUNITY AND MENTAL HEALTH AND LEARNING DISABILITY SERVICES (MULTILATERAL)

2012/13 NHS STANDARD CONTRACT FOR ACUTE, AMBULANCE, COMMUNITY AND MENTAL HEALTH AND LEARNING DISABILITY SERVICES (MULTILATERAL) E10d 2012/13 NHS STANDARD CONTRACT FOR ACUTE, AMBULANCE, COMMUNITY AND MENTAL HEALTH AND LEARNING DISABILITY SERVICES (MULTILATERAL) SECTION B PART 1 - SERVICE SPECIFICATIONS Service Specification No.

More information

Newer Aspects of Prostate Cancer Underwriting

Newer Aspects of Prostate Cancer Underwriting Newer Aspects of Prostate Cancer Underwriting Presented By: Jack Swanson, M.D. Keith Hoffman, NFP Moments Made Possible Objectives To review and discuss Conflicting messages about PSA testing Cautions

More information

Prostate Cancer Screening. A Decision Guide

Prostate Cancer Screening. A Decision Guide Prostate Cancer Screening A Decision Guide This booklet was developed by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). Is screening right for you?

More information

3.1 Investigations for Patients Presenting with Haematuria Table 1

3.1 Investigations for Patients Presenting with Haematuria Table 1 3.1 Investigations for Patients Presenting with Haematuria Table 1 Patients at risk of bacterial endocarditis should be given antibiotic prophylaxis as per local guidelines. Patients with heart valve replacements

More information

PSA testing in New Zealand general practice

PSA testing in New Zealand general practice PSA testing in New Zealand general practice Ross Lawrenson, Charis Brown, Fraser Hodgson. On behalf of the Midland Prostate Cancer Study Group Academic Steering Goup: Zuzana Obertova, Helen Conaglen, John

More information

Prostate Overview Quiz

Prostate Overview Quiz Prostate Overview Quiz 1. The path report reads: Gleason 3 + 4 = 7. The Gleason s score is a. 3 b. 4 c. 7 d. None of the above 2. The path report reads: Moderately differentiated adenocarcinoma of the

More information

Bringing prostate cancer education to regional and rural Australian communities

Bringing prostate cancer education to regional and rural Australian communities Bringing prostate cancer education to regional and rural Australian communities Julie Sykes 1, Lisa Fodero 2, Nick Brook 3, Rachel Jenkin 4 1 Prostate Cancer Foundation of Australia; 2 Health Consult;

More information

Your urgent assessment in head and neck

Your urgent assessment in head and neck Your urgent assessment in head and neck This leaflet will answer some of your questions about why you have been sent to us for an urgent assessment, and what the tests might involve. If you have more questions,

More information

18-Oct-16. Take home messages. An update for GPs on modern radiation therapy & hormones for prostate cancer. Session plan

18-Oct-16. Take home messages. An update for GPs on modern radiation therapy & hormones for prostate cancer. Session plan An update for GPs on modern radiation therapy & hormones for prostate cancer A/Prof Jeremy Millar Director Radiation Oncology, Alfred Health Clinical lead Prostate Cancer Outcomes Registry, Monash University

More information

Peninsula Cancer Alliance Update Nov 2018 UROLGY SSG

Peninsula Cancer Alliance Update Nov 2018 UROLGY SSG Peninsula Cancer Alliance Update Nov 2018 UROLGY SSG National Support Funding NHS England has allocated National Support Funding (NSF) to the Peninsula Cancer Alliance (PCA) for 2018/19 a proportion of

More information

NATIONAL REHABILITATION HOSPITAL SPINAL CORD SYSTEM OF CARE (SCSC) OUTPATIENT SCOPE OF SERVICE

NATIONAL REHABILITATION HOSPITAL SPINAL CORD SYSTEM OF CARE (SCSC) OUTPATIENT SCOPE OF SERVICE NATIONAL REHABILITATION HOSPITAL SPINAL CORD SYSTEM OF CARE (SCSC) OUTPATIENT SCOPE OF SERVICE Introduction: The Spinal Cord System of Care (SCSC) at the National Rehabilitation Hospital (NRH) provides

More information

THE UROLOGY GROUP

THE UROLOGY GROUP THE UROLOGY GROUP www.urologygroupvirginia.com 1860 Town Center Drive Suite 150/160 Reston, VA 20190 703-480-0220 19415 Deerfield Avenue Suite 112 Leesburg, VA 20176 703-724-1195 224-D Cornwall Street,

More information

Direct Access Physiotherapy: Challenges and Benefits of a UK Model

Direct Access Physiotherapy: Challenges and Benefits of a UK Model Dobrodosli Direct Access Physiotherapy: Challenges and Benefits of a UK Model Bradley Scanes MSc BSc (Hons) PGcert Chartered Physiotherapist (CSP, HCPC & ACPSEM Member) Kdo Sem Who Am I? A physio NHS Football

More information

Transrectal Ultrasound and Guide Biopsies of the Prostate

Transrectal Ultrasound and Guide Biopsies of the Prostate Transrectal Ultrasound and Guide Biopsies of the Prostate Patient Information Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm

More information

Active Surveillance for Prostate Cancer

Active Surveillance for Prostate Cancer PATIENT & CAREGIVER EDUCATION Active Surveillance for Prostate Cancer This information explains a treatment for prostate cancer called active surveillance. Not all prostate cancers are the same. Some may

More information

Diagnostic laparoscopy: procedure-specific information

Diagnostic laparoscopy: procedure-specific information PATIENT INFORMATION Diagnostic laparoscopy: procedure-specific information What is the evidence base for this information? This leaflet includes advice from consensus panels, the British Association of

More information

Bladder tumour resection (TURBT): procedure-specific information

Bladder tumour resection (TURBT): procedure-specific information PATIENT INFORMATION Bladder tumour resection (TURBT): procedure-specific information What is the evidence base for this information? This leaflet includes advice from consensus panels, the British Association

More information

Inspection/examination of the ureter & biopsy : procedure-specific information

Inspection/examination of the ureter & biopsy : procedure-specific information PATIENT INFORMATION Inspection/examination of the ureter & biopsy : procedure-specific information What is the evidence base for this information? This leaflet includes advice from consensus panels, the

More information

Mr Jeremy Grummet, Urological Surgeon MBBS, MS, FRACS Foundation 49 Men s Health Symposium August 2015

Mr Jeremy Grummet, Urological Surgeon MBBS, MS, FRACS Foundation 49 Men s Health Symposium August 2015 www.drjeremygrummet.com.au www.aua.com.au Mr Jeremy Grummet, Urological Surgeon MBBS, MS, FRACS Foundation 49 Men s Health Symposium August 2015 The dilemma Most men die with prostate cancer rather than

More information

16:30-18:30 WS #67: Urology Forum - Prostate Cancer, Stones, Renal Tumours, Voiding Dysfunction (120 minutes, not repeated) -

16:30-18:30 WS #67: Urology Forum - Prostate Cancer, Stones, Renal Tumours, Voiding Dysfunction (120 minutes, not repeated) - Dr Anna Lawrence Urologist Auckland Dr Andrew Williams Urologist Auckland Madhu Koya Urologist Auckland Andrew Lienert Urologist Auckland Dr Louise Tomlinson Consultant Gynaecologist Auckland 16:30-18:30

More information

Rapid access prostate imaging and diagnosis pathway Information for patients, relatives and carers

Rapid access prostate imaging and diagnosis pathway Information for patients, relatives and carers Rapid access prostate imaging and diagnosis pathway Information for patients, relatives and carers This leaflet explains more about the Rapid access prostate imaging and diagnosis pathway (RAPID), including

More information

INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM)

INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT NECN N Tees & Hartlepool North Tees And Hartlepool Date Self Assessment Completed 23rd July 2009 Date of IV Review 19th June 2009

More information

Having a transperineal prostate biopsy

Having a transperineal prostate biopsy Having a transperineal prostate biopsy This leaflet should help to answer some of your questions about having a transperineal prostate biopsy. If you have any further questions, please speak to a doctor

More information

Single Suspected Cancer Pathway Definitions pathway start date

Single Suspected Cancer Pathway Definitions pathway start date Single Suspected Cancer Pathway Definitions pathway start date Date: December 2018 Version: 8.0 Wales Cancer Owner: Network and Welsh Government Status Draft 1 P a g e Purpose of Document This document

More information

Prostate cancer. A guide for men who ve just been diagnosed

Prostate cancer. A guide for men who ve just been diagnosed Prostate cancer A guide for men who ve just been diagnosed 2 Prostate cancer A guide for men who ve just been diagnosed About this booklet This booklet is for men who ve recently been diagnosed with prostate

More information

Radical removal of the kidney (radical nephrectomy): procedure-specific information

Radical removal of the kidney (radical nephrectomy): procedure-specific information PATIENT INFORMATION Radical removal of the kidney (radical nephrectomy): procedure-specific information What is the evidence base for this information? This leaflet includes advice from consensus panels,

More information

Case studies: LUTS. Case 1 history. Case 1 - questions. Case 1 - outcome. Case 2 - history. Case 1 learning point 14/07/2015 DR JON REES

Case studies: LUTS. Case 1 history. Case 1 - questions. Case 1 - outcome. Case 2 - history. Case 1 learning point 14/07/2015 DR JON REES Case 1 history Case studies: LUTS DR JON REES A 49 year old male comes to see you he has had gradual deterioration of his flow over the last few years- he saw a colleague of yours 6 weeks ago who recorded

More information

Haematuria and Modern Bladder Cancer Treatment

Haematuria and Modern Bladder Cancer Treatment Haematuria and Modern Bladder Cancer Treatment Mr Nikhil Vasdev MBBS MRCS MCh(Urol) FRCS(Urol) RCSEng/BAUS Robotic Fellowship Accredited and Trained Consultant Urological and Robotic Surgeon Hertfordshire

More information

Do rural cancer patients present later than those in the city?

Do rural cancer patients present later than those in the city? Do rural cancer patients present later than those in the city? Dr Katie Hoff ( M.B.B.S.) Acknowledgements: Prof. J. Emery, V. Gray, D. Howting September 2011 BACKGROUND Cancer is a leading causes of death

More information

Patient Information. Prostate Tissue Ablation. High Intensity Focused Ultrasound for

Patient Information. Prostate Tissue Ablation. High Intensity Focused Ultrasound for High Intensity Focused Ultrasound for Prostate Tissue Ablation Patient Information CAUTION: Federal law restricts this device to sell by or on the order of a physician CONTENT Introduction... 3 The prostate...

More information

Haematuria Clinic. Information for patients Urology PROUD TO MAKE A DIFFERENCE SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST

Haematuria Clinic. Information for patients Urology PROUD TO MAKE A DIFFERENCE SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST Haematuria Clinic Information for patients Urology PROUD TO MAKE A DIFFERENCE SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST The Haematuria Clinic You have been referred to the Haematuria Clinic as

More information

Chemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:...

Chemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:... Coping, now your chemotherapy is finishing [ovarian cancer] Patient Information Series PI 41a East and North Hertfordshire NHS Trust 2 Contacts Chemotherapy Suite:... 020 3826 2236 [Mon - Fri, 8.00am -

More information

Sclerotherapy for Venous Vascular and Lymphatic Malformations

Sclerotherapy for Venous Vascular and Lymphatic Malformations Service: Imaging Sclerotherapy for Venous Vascular and Lymphatic Malformations Exceptional healthcare, personally delivered Your doctor has requested that you have sclerotherapy. We hope that the following

More information

Understanding the risk of recurrence after primary treatment for prostate cancer. Aditya Bagrodia, MD

Understanding the risk of recurrence after primary treatment for prostate cancer. Aditya Bagrodia, MD Understanding the risk of recurrence after primary treatment for prostate cancer Aditya Bagrodia, MD Aditya.bagrodia@utsouthwestern.edu 423-967-5848 Outline and objectives Prostate cancer demographics

More information

What is Cancer? Treatment. What is a MDT meeting?

What is Cancer? Treatment. What is a MDT meeting? i If you need your information in another language or medium (audio, large print, etc) please contact Customer Care on 0800 374 208 or send an email to: customercare@ salisbury.nhs.uk You are entitled

More information

CONTINENCE MODULE 1 MIMIMUM STANDARDS FOR THE SPECIALIST ASSESSMENT & CONSERVATIVE MANAGEMENT OF FEMALE LOWER URINARY TRACT SYMPTOMS

CONTINENCE MODULE 1 MIMIMUM STANDARDS FOR THE SPECIALIST ASSESSMENT & CONSERVATIVE MANAGEMENT OF FEMALE LOWER URINARY TRACT SYMPTOMS CONTINENCE MODULE 1 MIMIMUM STANDARDS FOR THE SPECIALIST ASSESSMENT & CONSERVATIVE MANAGEMENT OF FEMALE LOWER URINARY TRACT SYMPTOMS The minimum standards required to initiate specialised conservative

More information

Restorative dentistry new patient clinic

Restorative dentistry new patient clinic Restorative dentistry new patient clinic You have been referred to the Restorative Dentistry Service for an assessment regarding a specific dental problem, and this leaflet provides information about your

More information

Guidelines for the Shared Care of Patients on hormonal therapy for Prostate Cancer

Guidelines for the Shared Care of Patients on hormonal therapy for Prostate Cancer Peterborough City Hospital Department of Urology Guidelines for the Shared Care of Patients on hormonal therapy for Prostate Cancer Hormonal Therapy - How does it work? Prostate Cancer relies on the presence

More information

Non-QPP Measures 3 AQUA12. 6 AQUA15 Stones: Urinalysis documented 30 days before

Non-QPP Measures 3 AQUA12. 6 AQUA15 Stones: Urinalysis documented 30 days before Non-QPP Measures 1 Measure ID Measure Title Definition Type Domain AQUA3 (inverse) Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys Percentage of patients (boys) =< 18 years of age

More information

Evaluation of Cancer Outcomes Barwon South West Registry

Evaluation of Cancer Outcomes Barwon South West Registry Evaluation of Cancer Outcomes Barwon South West Registry Data Request Form Applicant details Applicant name: Position: Email: Project start date: Date: Telephone: Project completion date: Project details

More information

Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA

Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA ESMO Cape Town 14 Feb 2018 Disclosures Advisory boards/lecturer/consultant-

More information

OFFICIAL. Document Status. NHS England INFORMATION READER BOX

OFFICIAL. Document Status. NHS England INFORMATION READER BOX NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Strategy & Innovation Finance Publications Gateway Reference: 07925

More information

Prostate Cancer: A Primary Care Perspective

Prostate Cancer: A Primary Care Perspective + Prostate Cancer: A Primary Care Perspective Dr Jon Rees Tackle Conference, June 2015 + Current Activities + Current Activities + The state of UK Primary Care + A system under strain 24% increase in

More information

PARTICULARS, SCHEDULE 2- THE SERVICES, A- SERVICE SPECIFICATIONS. A08/S/d Colorectal: Faecal Incontinence (Adult)

PARTICULARS, SCHEDULE 2- THE SERVICES, A- SERVICE SPECIFICATIONS. A08/S/d Colorectal: Faecal Incontinence (Adult) A08/S/d 2013/14 NHS STANDARD CONTRACT FOR COLORECTAL: FAECAL INCONTINENCE (ADULT) PARTICULARS, SCHEDULE 2- THE SERVICES, A- SERVICE SPECIFICATIONS Service Specification No. Service Commissioner Lead Provider

More information

Your Guide to Prostate Cancer

Your Guide to Prostate Cancer Your Guide to Prostate Cancer If you face a diagnosis of prostate cancer, what s next? We can help. A prostate cancer diagnosis can be overwhelming. The good news is that while prostate cancer can be serious,

More information

Prostate Ultrasound Scan and Biopsies. Macclesfield District General Hospital

Prostate Ultrasound Scan and Biopsies. Macclesfield District General Hospital Prostate Ultrasound Scan and Biopsies Macclesfield District General Hospital Urology For clinical enquiries phone 01625 661517 Ultrasound For appointment enquires phone 01625 661384 @EastCheshireNHS Leaflet

More information

The Leeds Teaching Hospitals NHS Trust Prostate Brachytherapy using High Dose Rate (HDR) Temporary Brachytherapy Implants

The Leeds Teaching Hospitals NHS Trust Prostate Brachytherapy using High Dose Rate (HDR) Temporary Brachytherapy Implants n The Leeds Teaching Hospitals NHS Trust Prostate Brachytherapy using High Dose Rate (HDR) Temporary Brachytherapy Implants Information for patients This leaflet aims to explain what happens when you have

More information

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group

More information

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital 01/02/2018 Lower Urinary Tract Symptoms LUTS - one of

More information

Cancer of Unknown Primary Service

Cancer of Unknown Primary Service Cancer of Unknown Primary Service Dr Maurice Fernando Consultant In Specialist Palliative Care and CUP lead Doncaster and Bassetlaw Hospitals NHS FT Wakefield meeting -14-07-2016 CUP service CUP MDT

More information